Nanotech nurtures unique treatment for inoperable cancers
pharmaphorum - 18-Dec-2020Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer
Join the club for FREE to access the whole archive and other member benefits.
CEO and Founder at Active Needle Technology Ltd
Ian Quirk, CEO and Co-founder of Active Needle, trained initially as a chemist and began working in product development before gaining expertise at a senior management level in regulatory affairs. As a member of the Institute of Directors and Institute of Clinical Research, Ian has over ten years’ senior management experience in medtech companies and has worked in various markets including orthopaedic, vascular and coronary, paediatric cardiology, ocular, imaging and in-vitro diagnostics.
See also: Active Needle Technology - Medical device start-up company based in Abingdon, United Kingdom
Details last updated 19-Dec-2020
Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer